# Ernexa Therapeutics Inc.: Form DEF 14A, filed Apr 22, 2016

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: DEF 14A
- Filed: 2016-04-22
- Accepted by EDGAR: Apr 22, 2016, 16:31 ET
- Period: 2016-04-22
- Accession: 0001493152-16-009130
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315216009130/def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315216009130/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315216009130/def14a.htm

Filed Apr 22, 2016.
Source: SEC EDGAR, the filing index for accession 0001493152-16-009130. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
